Physician

Joel Martin Laudenbach, DMD

According to 2025 Medicare claims, Joel Laudenbach, DMD (NPI: 1225235203) practices oral surgery (dentists only) in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (NPI: 1104289685; TIN: 560529945) and primary practice location at 28209-3825. Laudenbach is affiliated with the Carolinas HealthCare System ACO, LLC (ACO ID: A3675), participating under the MSSP model.

Laudenbach's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 141 traditional Medicare patients, billed 247 HCPCS/CPT codes, and received $20,913 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 461 prescription claims across 141 beneficiaries totaling $13,906 in drug costs, led by Dexamethasone (Dexamethasone). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $3,732 to $13,906. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$14K$29K2018 Medicare payment: $9,473 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $20,827 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $18,405 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $25,173 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $21,831 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $28,617 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $20,913 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
201859148$9,473
2019141303$20,827
2020114226$18,405
2021143270$25,173
2022137246$21,831
2023175314$28,617
2024141247$20,913

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$9.8K$20K2015 Drug cost: $3,732 (USD; Tot_Drug_Cst)2016 Drug cost: $4,450 (USD; Tot_Drug_Cst)2017 Drug cost: $3,832 (USD; Tot_Drug_Cst)2018 Drug cost: $7,004 (USD; Tot_Drug_Cst)2019 Drug cost: $13,939 (USD; Tot_Drug_Cst)2020 Drug cost: $12,679 (USD; Tot_Drug_Cst)2021 Drug cost: $12,133 (USD; Tot_Drug_Cst)2022 Drug cost: $17,125 (USD; Tot_Drug_Cst)2023 Drug cost: $19,599 (USD; Tot_Drug_Cst)2024 Drug cost: $13,906 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151342$3,732
20161348$4,450
20172548$3,832
201864168$7,004
2019116320$13,939
2020103351$12,679
2021116400$12,133
2022126428$17,125
2023141496$19,599
2024141461$13,906

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more5959$110
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4768$89
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more6385$57

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
DexamethasoneDexamethasone833,473$3,428
NystatinNystatin1043,442$2,457
Clobetasol PropionateClobetasol Propionate29935$2,382
TacrolimusTacrolimus15465$1,420
ClotrimazoleClotrimazole432,478$1,204

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Joel Martin Laudenbach, DMD?

Tedicare shows public-source Medicare data for Joel Martin Laudenbach, DMD (NPI 1225235203), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joel Martin Laudenbach, DMD have ACO affiliation data?

Joel Martin Laudenbach, DMD is shown with ACO affiliation data for Carolinas HealthCare System ACO, LLC (MSSP, ACO ID A3675).

What billing organization is linked to Joel Martin Laudenbach, DMD?

Joel Martin Laudenbach, DMD is linked to THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (billing NPI 1104289685) in the available physician profile data.

Does Joel Martin Laudenbach, DMD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.